Ascendis Pharma (ADR)
Builds and commercializes rare-endocrinology medicines through the TransCon prodrug platform.
$247.91
After-hours close0.00 (0.00%)
At close$247.91(−0.58%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $1.24 | — | — |
| Aug 2026 | $1.71 | $3.29 | +92.4% |
| May 2026 | $0.21 | $0.32 | +52.4% |
| Feb 2026 | −$0.06 | −$0.64 | −966.7% |
| Nov 2025 | −$0.41 | −$1.17 | −185.4% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Sep 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Dec 2020 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Apr 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Apr 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Dec 2015 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | $1.24 | — | — | $488.6M | — | — |
| Aug 13, 2026 | $1.71 | $3.29 | +92.4% | $376.8M | $387.5M | +2.8% |
| May 7, 2026 | $0.21 | $0.32 | +52.4% | $363.2M | $335.0M | −7.8% |
| Feb 11, 2026 | −$0.06 | −$0.64 | −966.7% | $292.3M | $344.8M | +18.0% |
| Nov 12, 2025 | −$0.41 | −$1.17 | −185.4% | $302.6M | $250.2M | −17.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 1, 2025 | ||||||
| Feb 12, 2025 | ||||||
| Nov 14, 2024 | ||||||
| Sep 3, 2024 | ||||||
| May 2, 2024 | ||||||
| Feb 7, 2024 | ||||||
| Nov 7, 2023 | ||||||
| Aug 16, 2023 | ||||||
| Apr 27, 2023 | ||||||
| Feb 16, 2023 | ||||||
| Nov 2, 2022 | ||||||
| Aug 10, 2022 | ||||||
| May 11, 2022 | ||||||
| Mar 2, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Aug 25, 2021 | ||||||
| May 27, 2021 | ||||||
| Dec 31, 2020 | ||||||
| Nov 11, 2020 | ||||||
| Aug 27, 2020 | ||||||
| May 19, 2020 | ||||||
| Apr 1, 2020 | ||||||
| Nov 18, 2019 | ||||||
| Aug 28, 2019 | ||||||
| May 30, 2019 | ||||||
| Apr 3, 2019 | ||||||
| Nov 28, 2018 | ||||||
| Aug 29, 2018 | ||||||
| May 30, 2018 | ||||||
| Mar 28, 2018 | ||||||
| Nov 16, 2017 | ||||||
| Aug 18, 2017 | ||||||
| May 23, 2017 | ||||||
| Mar 22, 2017 | ||||||
| Nov 30, 2016 | ||||||
| Aug 31, 2016 | ||||||
| May 19, 2016 | ||||||
| Dec 31, 2015 | ||||||
| Nov 12, 2015 | ||||||
| Aug 24, 2015 | ||||||